NCT03301857 · BASELINE
Baseline characteristics
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- denoms
- counts
- group Id
- BG000
- value
- 51
- group Id
- BG001
- value
- 34
- group Id
- BG002
- value
- 85
- units
- Participants
- groups
- description
- Participants who received denosumab at the conclusion of study 20062004 continued in this study (study 20140114), and received denosumab at the current dose (120 mg Q4W SC) and schedule at the investigator's discretion.
- id
- BG000
- title
- Exposed to IP
- description
- Participants who completed denosumab treatment in study 20062004 and were in the safety follow up at the conclusion of study 20062004 continued in long term safety follow up in this study (study 20140114), and did not receive denosumab.
- id
- BG001
- title
- Not Exposed to IP
- description
- Total of all reporting groups
- id
- BG002
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 12.8
- value
- 42.4
- group Id
- BG001
- spread
- 15.1
- value
- 46.7
- group Id
- BG002
- spread
- 13.9
- value
- 44.1
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- Years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 32
- group Id
- BG001
- value
- 23
- group Id
- BG002
- value
- 55
- title
- Female
- measurements
- group Id
- BG000
- value
- 19
- group Id
- BG001
- value
- 11
- group Id
- BG002
- value
- 30
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 13
- group Id
- BG001
- value
- 10
- group Id
- BG002
- value
- 23
- title
- Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 38
- group Id
- BG001
- value
- 24
- group Id
- BG002
- value
- 62
- title
- Not Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Ethnicity (NIH/OMB)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 35
- group Id
- BG001
- value
- 31
- group Id
- BG002
- value
- 66
- title
- White
- categories
- measurements
- group Id
- BG000
- value
- 10
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 10
- title
- Other
- categories
- measurements
- group Id
- BG000
- value
- 4
- group Id
- BG001
- value
- 3
- group Id
- BG002
- value
- 7
- title
- Black (or African American)
- categories
- measurements
- group Id
- BG000
- value
- 2
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 2
- title
- Asian
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race/Ethnicity, Customized
- unit Of Measure
- Participants
- population Description
- Full analysis set (FAS) included all enrolled participants (from study 20062004) who provided informed consent and had a non-missing enrolment date in this study.
Complete source fields
- denoms
- counts
- group Id
- BG000
- value
- 51
- group Id
- BG001
- value
- 34
- group Id
- BG002
- value
- 85
- units
- Participants
- groups
- description
- Participants who received denosumab at the conclusion of study 20062004 continued in this study (study 20140114), and received denosumab at the current dose (120 mg Q4W SC) and schedule at the investigator's discretion.
- id
- BG000
- title
- Exposed to IP
- description
- Participants who completed denosumab treatment in study 20062004 and were in the safety follow up at the conclusion of study 20062004 continued in long term safety follow up in this study (study 20140114), and did not receive denosumab.
- id
- BG001
- title
- Not Exposed to IP
- description
- Total of all reporting groups
- id
- BG002
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 12.8
- value
- 42.4
- group Id
- BG001
- spread
- 15.1
- value
- 46.7
- group Id
- BG002
- spread
- 13.9
- value
- 44.1
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- Years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 32
- group Id
- BG001
- value
- 23
- group Id
- BG002
- value
- 55
- title
- Female
- measurements
- group Id
- BG000
- value
- 19
- group Id
- BG001
- value
- 11
- group Id
- BG002
- value
- 30
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 13
- group Id
- BG001
- value
- 10
- group Id
- BG002
- value
- 23
- title
- Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 38
- group Id
- BG001
- value
- 24
- group Id
- BG002
- value
- 62
- title
- Not Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Ethnicity (NIH/OMB)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 35
- group Id
- BG001
- value
- 31
- group Id
- BG002
- value
- 66
- title
- White
- categories
- measurements
- group Id
- BG000
- value
- 10
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 10
- title
- Other
- categories
- measurements
- group Id
- BG000
- value
- 4
- group Id
- BG001
- value
- 3
- group Id
- BG002
- value
- 7
- title
- Black (or African American)
- categories
- measurements
- group Id
- BG000
- value
- 2
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 2
- title
- Asian
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race/Ethnicity, Customized
- unit Of Measure
- Participants
- population Description
- Full analysis set (FAS) included all enrolled participants (from study 20062004) who provided informed consent and had a non-missing enrolment date in this study.
Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0
Preserved source evidence · Not medical advice
Triangle